PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+46.43%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$153M
AUM Growth
+$153M
(+40%)
Cap. Flow
+$4.01M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
41.14%
Holding
109
New
16
Increased
26
Reduced
37
Closed
9
Top Buys
| 1 |
Cantaloupe
CTLP
|
$2.67M |
| 2 |
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
|
$2.2M |
| 3 |
Elutia
ELUT
|
$1.9M |
| 4 |
SHSP
SharpSpring, Inc.
SHSP
|
$1.72M |
| 5 |
INTZ
INTRUSION INC NEW
INTZ
|
$1.07M |
Top Sells
| 1 |
Magnite
MGNI
|
$2.63M |
| 2 |
BioLife Solutions
BLFS
|
$1.06M |
| 3 |
QUMU
Qumu Corp.
QUMU
|
$1M |
| 4 |
Digital Turbine
APPS
|
$989K |
| 5 |
NeoGenomics
NEO
|
$984K |
Sector Composition
| 1 | Healthcare | 64.3% |
| 2 | Technology | 12.83% |
| 3 | Communication Services | 8.46% |
| 4 | Industrials | 4.04% |
| 5 | Consumer Staples | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOR
26
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $2.2M | 1.44% | +413,475 | New | +$2.2M |
|
|
VG
27
DELISTED
Vonage Holdings Corporation
VG
| $2.01M | 1.31% | 156,025 +1,975 | +1% | +$25.4K |
|
|
ATRS
28
DELISTED
Antares Pharma, Inc.
ATRS
| $1.92M | 1.25% | 480,783 +254,250 | +112% | +$1.01M |
|
|
29
Elutia
ELUT
$96.7M
| $1.9M | 1.24% | +139,375 | New | +$1.9M |
|
|
QUMU
30
DELISTED
Qumu Corp.
QUMU
| $1.89M | 1.23% | 235,860 -125,140 | -35% | -$1M |
|
31
Pfizer
PFE
$141B
| $1.82M | 1.19% | 49,548 +1,175 | +2% | +$43.3K |
|
32
Exagen
XGN
$217M
| $1.75M | 1.14% | 132,355 +12,000 | +10% | +$158K |
|
|
SHSP
33
DELISTED
SharpSpring, Inc.
SHSP
| $1.72M | 1.12% | +105,325 | New | +$1.72M |
|
|
ASPU
34
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.64M | 1.07% | 147,250 -5,500 | -4% | -$61.2K |
|
|
PFIE
35
DELISTED
Profire Energy, Inc
PFIE
| $1.58M | 1.03% | 1,853,989 +833,500 | +82% | +$711K |
|
|
CSLT
36
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.57M | 1.02% | 1,204,000 -21,750 | -2% | -$28.3K |
|
|
37
BioLife Solutions
BLFS
$1.2B
| $1.48M | 0.97% | 37,000 -26,650 | -42% | -$1.06M |
|
38
Target
TGT
$43.6B
| $1.43M | 0.93% | 8,079 -450 | -5% | -$79.4K |
|
39
AbbVie
ABBV
$372B
| $1.31M | 0.85% | 12,188 -900 | -7% | -$96.4K |
|
40
AT&T
T
$209B
| $1.15M | 0.75% | 40,079 -750 | -2% | -$21.6K |
|
41
3M
MMM
$82.8B
| $1.15M | 0.75% | 6,556 +700 | +12% | +$122K |
|
|
INTZ
42
DELISTED
INTRUSION INC NEW
INTZ
| $1.07M | 0.7% | +60,500 | New | +$1.07M |
|
43
Verizon
VZ
$186B
| $1.04M | 0.68% | 17,725 +1,850 | +12% | +$109K |
|
|
AVGR
44
DELISTED
Avinger, Inc. Common Stock
AVGR
| $1.03M | 0.67% | 2,337,400 -14,000 | -0.6% | -$6.16K |
|
45
Bristol-Myers Squibb
BMY
$96B
| $1.02M | 0.67% | 16,450 -300 | -2% | -$18.6K |
|
46
Merck
MRK
$210B
| $1M | 0.66% | 12,275 -500 | -4% | -$40.9K |
|
47
Ciena
CIEN
$13.3B
| $965K | 0.63% | 18,250 | – | – |
|
|
STRM
48
DELISTED
Streamline Health Solutions
STRM
| $945K | 0.62% | 605,850 +172,100 | +40% | +$268K |
|
49
QuickLogic
QUIK
$84.3M
| $931K | 0.61% | 245,602 -113,386 | -32% | -$430K |
|
50
Vision Marine Technologies
VMAR
$4.43M
| $881K | 0.58% | +65,510 | New | +$881K |
|